References
Ames BN. Endogenous oxidative DNA damage, aging, and cancer. Free Radical Research Communications 7: 121–128, 1989
Berlin RG. Omeprazole — gastrin and gastric endocrine cell data from clinical studies. Digestive Diseases and Sciences 36: 129–136, 1991
Brillinger RL, Nestmann ER, Sigal EA, Swierenga SH. Recommended protocols based on a survey of current practice. Mutation Research 246: 323–330, 1991
Burlinson B. An in vivo unscheduled DNA synthesis (UDS) assay in the rat gastric mucosa: preliminary development. Carcinogenesis 10: 1425–1428, 1989
Burlinson B, Morriss SH, Gatehouse DG, Tweats DJ. Genotoxicity of gastric acid inhibiting drugs. Correspondence. Lancet 335: 419–420, 1990
Burlinson B, Morriss S, Gatehouse DG, Tweats DJ, Jackson MR. Uptake of tritiated-thymidine by cells of the rat gastric-mucosa after exposure to loxtidine or omeprazole. Mutagenesis 6: 11–18, 1991
Calam J, Goodlad RA, Lee CY, Ratcliffe B, Coates ME, et al. Achlorhydria-induced hypergastinaemia: the role of bacteria. Clinical Science 80: 281–284, 1991
Carlsson E, Havu N, Mattsson H, Ekman L. Gastrin and gastric enterochromaffin-like cell carcinoids in the rat. Digestion 47(Suppl. 1): 17–23, 1990
Creutzfeldt W, Lamberts R, Stockmann F, Brunner G. Quantitative studies of gastric endocrine cells in patients receiving long-term treatment with omeprazole. Scandinavian Journal of Gastroenterology (Suppl. 166): 122–128, 1989
D’Adda T, Pilato FP, Lazzaroni M, Robutti F, Bianchi PG, et al. Ultrastructural morphometry of gastric endocrine cells before and after omeprazole. A study in the oxyntic mucosa of duodenal ulcer patients. Gastroenterology 100: 1563–1570, 1991
Deprez PH, Ghosh P, Goodlad RA, Lacey SL, Millership S, et al. Hypergastrinaemia: a new mechanism. Lancet 338: 410–411, 1991
Editorial. Omeprazole and genotoxicity. Lancet 335: 386, 1990
Eggstein S, Imadhl A, Kohler M, Waibel M, Farthman EH. Influence of gastrin, gastrin receptor blockers, epidermal growth factors and difluomethylornithine on the growth and activity of ornithine decarboxylase on colonic carcinoma cells. Journal of Cancer Research and Clinical Oncology 117: 37–42, 1991
Eissele R, Rosskopf B, Koop H, Adler G, Arnold R. Proliferation of endocrine cells in the rat stomach caused by drug-induced achlorhydria. Gastroenterology 101: 70–76, 1991
Ekman L, Bolcsfoldi G, Macdonald J, Nicois W. Reply. Lancet 335: 419–420, 1990
Evans HJ. Tests for genotoxicity — principles and findings in relation to omeprazole. Digestion 47(Suppl. 1) 45–48, 1990
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61: 759–767, 1990
Fraser AG, Debnam ES, Dhillon AP, Pounder RE. Gastric epithelial cell proliferation after dosing with anti-secretory drugs: the effect of variation in two strains of rat. European Journal of Gastroenterology and Hepatology 4: 651–656, 1992
Furihata C, Hirose K, Matsushima T. Genotoxicity and cell proliferative activity of omeprazole in rat stomach mucosa. Mutation Research 262: 73–76, 1991
Goodlad RA. The whole crypt and nothing but the crypt. European Journal of Gastroenterology and Hepatology 4: 1035–1036, 1992
Goodlad RA. Increased cell proliferation as a cause of human cancer. Workshop report. In Waldron et al. (Eds) Food and cancer prevention: chemical and biolgical aspects, pp. 300–301, Royal Society of Chemistry, Cambridge, 1993
Goodlad RA, Al-Mukhtar MYT, Ghatei MA, Bloom SB, Wright NA. Cell proliferation, plasma enteroglucagon and plasma gastrin in starved and refed rats. Virchows Archiv. B. Cell Pathology 43: 55–62, 1983
Goodlad RA, Lee CY, Alison MR, Sarraf CE, Ghatei MA, et al. Evaluation of a proposed technique to assess unscheduled DNA synthesis and genotoxicity. Gut 34: 235–241, 1993
Goodlad RA, Madgwick AJA, Moffatt MR, Levin S, Allen JL, et al. Prostaglandins and the gastric epithelium: effects of misoprostol on gastric epithelial cell proliferation in the dog. Gut 30, 316–321, 1989
Goodlad RA, Madgwick AJA, Moffatt MR, Levin S, Allen JL, et al. Prostaglandins and the gastric epithelium: effects of misoprostol on cell migration and transit in the dog stomach. Gastroenterology 96: 1–6, 1990a
Goodlad RA, Madgwick AJA, Moffatt MR, Levin S, Allen JL, et al. Prostaglandins and the gastric epithelium: effects of misoprostol on gastric morphometry. Digestion 45: 212–217, 1990b
Goodlad RA, Wright NA. Growth control factors in the gastrointestinal tract. Bailliere’s Clinical Gastroenterology 4: 97–119, 1990
Goodlad RA, Wright NA. Omeprazole. British Medical Journal 303: 851, 1991a
Goodlad RA, Wright NA. Omeprazole and genotoxicity. Lancet 335, 909–910, 1991b
Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35: 42–55, 1986
Helander HF, Simonsson M, Sundler F, Rutgersson K, Helander KG, et al. Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists. Virchows Archiv. A. Pathological Anatomy and Histopathology 417: 305–309, 1990
Holt S, Howden CW. Omeprazole — overview and opinion. Digestive Diseases and Sciences 36: 385–393, 1991
Holt S, Powers RE. Howden CW Antisecretory therapy and genotoxicity. Digestive Diseases and Sciences 36: 545–547, 1991a
Holt S, Zhu ZH, Powers RE. Observations on a proposed measure of genotoxicity in rat gastric mucosa. Gastroenterology 101: 650, 1991b
Howden CW, Holt S. Omeprazole. British Medical Journal 303: 850–851, 1991
Johnson LR. Regulation of gastrointestinal growth. In Johnson LR (Ed.) Physiology of the digestive tract, pp. 169–196, Raven Press, New York, 1991
Langman MJS. Omeprazole. British Medical Journal 303; 481–482, 1991
Larsson H, Fryklund J, Helander HF, Wallmark B. Partial pronase digestion of rat gastric mucosa isolates cells undergoing replicative DNA synthsis. Mutagenesis 6: 3–9, 1991
Le Fanu J. Tests of strength in a drug war. The Independent on Sunday, pp. 51, 10 Jun 1990
Lewinski A, Rybicka I, Wajs E, Szkudlinski M, Pawlikowski M. Influence of pineal indoleamines on the mitotic-activity of gastric and colonic mucosa epithelial-cells in the rat — interaction with omeprazole. Journal of Pineal Research 10: 104–108, 1991
Maton PN. Drug-therapy — omeprazole. New England Journal of Medicine 324: 965–975, 1991
Pounder R. Correspondence. Lancet 335: 612, 1990
Preston-Martin S, Pike MC, Ross RK, Jones PA, Henderson BE. Increased cell division as a cause of human cancer. Cancer Research 50: 7415–7421, 1990
Ryberg B, Tielemans Y, Axelson J, Carlsson E, Hakanson R, et al. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology 99: 935–942, 1990
Sachs G, Scott D. Cell digestion and genotoxicity assessment in gastric mucosa. Digestion 47(Suppl. 1): 31–34, 1990
Sachs G, Scott D, Reuben M. Omeprazole and the gastric mucosa. Digestion 47(Suppl. 1): 35–38, 1990
Solcia E, Rindi G, Havu N, Elm G. Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scandinavian Journal of Gastroenterology (Suppl. 166): 129–137, 1989
Solcia E, Villani L, Luinetti O, Fiocca R. Proton pump inhibitors, enterochromaffin-like growth and Helicobacter pylori gastritis. Alimentary Pharmacology and Therapeutics (Suppl. 7): 25–28, 1989
Tielemans Y, Hakanson R, Sundler F, Willems G. Proliferation of enterochromaffin-like cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 96: 723–729, 1989
Williams GM. Methods for evaluating chemical genotoxicity. Annual Review of Pharmacology and Toxicology 29: 189–211, 1989
Wong K, Beardsall K, Waters CM, Calam J, Poston GJ. Postprandial hypergastrinaemia in patients with colorectal carcinoma. Gut 32: 1352–1354, 1991
Wright NA. DNA synthesis and genotoxicity. Digestion 47(Suppl.1): 24–30, 1990
Wright NA, Alison MR. The biology of epithelial cell populations, vol. 2, Oxford University Press, Oxford, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Goodlad, R.A. Acid Suppression and Claims of Genotoxicity. Drug-Safety 10, 413–419 (1994). https://doi.org/10.2165/00002018-199410060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199410060-00001